tetano
Editor, Senior Moderator
J Clin Invest
. 2022 Dec 1;e163669.
doi: 10.1172/JCI163669. Online ahead of print.
Impact of pre-existing chronic viral infection and reactivation on the development of long COVID
Michael J Peluso[SUP] 1 [/SUP], Tyler-Marie Deveau[SUP] 2 [/SUP], Sadie E Munter[SUP] 2 [/SUP], Dylan M Ryder[SUP] 2 [/SUP], Amanda M Buck[SUP] 2 [/SUP], Gabriele Beck-Engeser[SUP] 2 [/SUP], Fay Chan[SUP] 2 [/SUP], Scott Lu[SUP] 3 [/SUP], Sarah A Goldberg[SUP] 3 [/SUP], Rebecca Hoh[SUP] 1 [/SUP], Viva Tai[SUP] 1 [/SUP], Leonel Torres[SUP] 2 [/SUP], Nikita S Iyer[SUP] 2 [/SUP], Monika Deswal[SUP] 1 [/SUP], Lynn H Ngo[SUP] 1 [/SUP], Melissa Buitrago[SUP] 1 [/SUP], Antonio E Rodriguez[SUP] 1 [/SUP], Jessica Y Chen[SUP] 1 [/SUP], Brandon C Yee[SUP] 4 [/SUP], Ahmed Chenna[SUP] 5 [/SUP], John W Winslow[SUP] 5 [/SUP], Christos J Petropoulos[SUP] 5 [/SUP], Amelia N Deitchman[SUP] 6 [/SUP], Joanna Hellmuth[SUP] 7 [/SUP], Matthew A Spinelli[SUP] 1 [/SUP], Matthew S Durstenfeld[SUP] 8 [/SUP], Priscilla Y Hsue[SUP] 8 [/SUP], John Daniel Kelly[SUP] 3 [/SUP], Jeffrey N Martin[SUP] 3 [/SUP], Steven G Deeks[SUP] 1 [/SUP], Peter W Hunt[SUP] 2 [/SUP], Timothy J Henrich[SUP] 2 [/SUP]
Affiliations
Abstract
Background: The presence and reactivation of chronic viral infections such as Epstein-Barr virus (EBV), cytomegalovirus (CMV) and human immunodeficiency virus (HIV) have been proposed as potential contributors to Long COVID (LC), but studies in well-characterized post-acute cohorts of individuals with COVID-19 over a longer time course consistent with current case definitions of LC are limited.
Methods: In a cohort of 280 adults with prior SARS-CoV-2 infection, we assessed the presence and types of LC symptoms and prior medical history (including COVID-19 history and HIV status), and performed serological testing for EBV and CMV using a commercial laboratory. We used covariate-adjusted binary logistic regression models to identify independent associations between variables and LC symptoms.
Results: We observed that LC symptoms such as fatigue and neurocognitive dysfunction at a median of 4months following initial diagnosis were independently associated with serological evidence suggesting recent EBV reactivation (early antigen-D [EA-D] IgG positivity) or high nuclear antigen (EBNA) IgG levels, but not with ongoing EBV viremia. Serological evidence suggesting recent EBV reactivation (EA-D IgG) was most strongly associated with fatigue (OR 2.12). Underlying HIV infection was also independently associated with neurocognitive LC (OR 2.5). Interestingly, participants who had serologic evidence of prior CMV infection were less likely to develop neurocognitive LC (OR 0.52).
Conclusion: Overall, these findings suggest differential effects of chronic viral co-infections on the likelihood of developing LC and predicted distinct syndromic patterns. Further assessment during the acute phase of COVID-19 is warranted.
. 2022 Dec 1;e163669.
doi: 10.1172/JCI163669. Online ahead of print.
Impact of pre-existing chronic viral infection and reactivation on the development of long COVID
Michael J Peluso[SUP] 1 [/SUP], Tyler-Marie Deveau[SUP] 2 [/SUP], Sadie E Munter[SUP] 2 [/SUP], Dylan M Ryder[SUP] 2 [/SUP], Amanda M Buck[SUP] 2 [/SUP], Gabriele Beck-Engeser[SUP] 2 [/SUP], Fay Chan[SUP] 2 [/SUP], Scott Lu[SUP] 3 [/SUP], Sarah A Goldberg[SUP] 3 [/SUP], Rebecca Hoh[SUP] 1 [/SUP], Viva Tai[SUP] 1 [/SUP], Leonel Torres[SUP] 2 [/SUP], Nikita S Iyer[SUP] 2 [/SUP], Monika Deswal[SUP] 1 [/SUP], Lynn H Ngo[SUP] 1 [/SUP], Melissa Buitrago[SUP] 1 [/SUP], Antonio E Rodriguez[SUP] 1 [/SUP], Jessica Y Chen[SUP] 1 [/SUP], Brandon C Yee[SUP] 4 [/SUP], Ahmed Chenna[SUP] 5 [/SUP], John W Winslow[SUP] 5 [/SUP], Christos J Petropoulos[SUP] 5 [/SUP], Amelia N Deitchman[SUP] 6 [/SUP], Joanna Hellmuth[SUP] 7 [/SUP], Matthew A Spinelli[SUP] 1 [/SUP], Matthew S Durstenfeld[SUP] 8 [/SUP], Priscilla Y Hsue[SUP] 8 [/SUP], John Daniel Kelly[SUP] 3 [/SUP], Jeffrey N Martin[SUP] 3 [/SUP], Steven G Deeks[SUP] 1 [/SUP], Peter W Hunt[SUP] 2 [/SUP], Timothy J Henrich[SUP] 2 [/SUP]
Affiliations
- PMID: 36454631
- DOI: 10.1172/JCI163669
Abstract
Background: The presence and reactivation of chronic viral infections such as Epstein-Barr virus (EBV), cytomegalovirus (CMV) and human immunodeficiency virus (HIV) have been proposed as potential contributors to Long COVID (LC), but studies in well-characterized post-acute cohorts of individuals with COVID-19 over a longer time course consistent with current case definitions of LC are limited.
Methods: In a cohort of 280 adults with prior SARS-CoV-2 infection, we assessed the presence and types of LC symptoms and prior medical history (including COVID-19 history and HIV status), and performed serological testing for EBV and CMV using a commercial laboratory. We used covariate-adjusted binary logistic regression models to identify independent associations between variables and LC symptoms.
Results: We observed that LC symptoms such as fatigue and neurocognitive dysfunction at a median of 4months following initial diagnosis were independently associated with serological evidence suggesting recent EBV reactivation (early antigen-D [EA-D] IgG positivity) or high nuclear antigen (EBNA) IgG levels, but not with ongoing EBV viremia. Serological evidence suggesting recent EBV reactivation (EA-D IgG) was most strongly associated with fatigue (OR 2.12). Underlying HIV infection was also independently associated with neurocognitive LC (OR 2.5). Interestingly, participants who had serologic evidence of prior CMV infection were less likely to develop neurocognitive LC (OR 0.52).
Conclusion: Overall, these findings suggest differential effects of chronic viral co-infections on the likelihood of developing LC and predicted distinct syndromic patterns. Further assessment during the acute phase of COVID-19 is warranted.